A clinical trial evaluated the effectiveness of rizatriptan, a commonly used migraine medication, in providing rapid relief from vertigo or dizziness during vestibular migraine attacks. The study found that rizatriptan did not significantly reduce symptoms within 1 hour of onset and showed no advantage over placebo for rapid symptom relief, indicating it may be ineffective for treating vestibular migraine attacks. 

Source: JAMA Neurology